- Home
- ICCC vs GNTA Comparison
ICCC vs GNTA Comparison
Compare ICCC & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- GNTA
- Stock Information
- Founded
- ICCC 1982
- GNTA 2014
- Country
- ICCC United States
- GNTA Italy
- Employees
- ICCC N/A
- GNTA N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ICCC Health Care
- GNTA Health Care
- Exchange
- ICCC Nasdaq
- GNTA Nasdaq
- Market Cap
- ICCC 60.1M
- GNTA 62.9M
- IPO Year
- ICCC 1987
- GNTA 2021
- Fundamental
- Price
- ICCC $5.60
- GNTA $3.03
- Analyst Decision
- ICCC
- GNTA Strong Buy
- Analyst Count
- ICCC 0
- GNTA 1
- Target Price
- ICCC N/A
- GNTA $25.00
- AVG Volume (30 Days)
- ICCC 6.8K
- GNTA 16.3K
- Earning Date
- ICCC 11-12-2025
- GNTA 01-01-0001
- Dividend Yield
- ICCC N/A
- GNTA N/A
- EPS Growth
- ICCC N/A
- GNTA N/A
- EPS
- ICCC 0.20
- GNTA N/A
- Revenue
- ICCC $28,274,756.00
- GNTA N/A
- Revenue This Year
- ICCC N/A
- GNTA N/A
- Revenue Next Year
- ICCC N/A
- GNTA N/A
- P/E Ratio
- ICCC $29.40
- GNTA N/A
- Revenue Growth
- ICCC 21.75
- GNTA N/A
- 52 Week Low
- ICCC $3.34
- GNTA $2.56
- 52 Week High
- ICCC $7.60
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ICCC 35.75
- GNTA 51.84
- Support Level
- ICCC $5.59
- GNTA $2.56
- Resistance Level
- ICCC $6.42
- GNTA $3.69
- Average True Range (ATR)
- ICCC 0.27
- GNTA 0.21
- MACD
- ICCC -0.07
- GNTA -0.22
- Stochastic Oscillator
- ICCC 0.71
- GNTA 79.74
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.